Back to search

Peptide record

TPDB06356

Antibacterial Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06356
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 11-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
FAKWAFKWLKK
Physicochemical Analysis
C76H109N17O12
RNDCEQGHIMPSTYV
K
1452.81
11.00
4
0
7
+4
-2.90
-0.400
53.64
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
11000
757.15
0
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
1
L
4
K
0
M
2
F
0
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 4 M: 0 F: 2 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
11
C76H109N17O12
1452.81
11.00
+4
-2.90
-0.400
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

NA

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S. epidermid
Evidence 2 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

NA

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S. epidermidis ATCC 12228 (MIC 6.3 ug/ml), Gram- E
Evidence 3 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

NA

Other

gainst Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S. epidermidis ATCC 12228 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S.
Evidence 4 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Staphylococcus epidermidis ATCC 12228

Source & Reference

NA

Other

C 6.3 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S. epidermidis ATCC 12228 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 12.5 ug/ml), S.
Evidence 5 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

), S. aureus ATCC 6538p (MIC 6.3 ug/ml), S. epidermidis ATCC 12228 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 12.5 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K.
Evidence 6 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

S. dysentariae ATCC 9752

Source & Reference

NA

Other

l), S. epidermidis ATCC 12228 (MIC 6.3 ug/ml), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 12.5 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumonia ATCC 10031 (MIC 6.3 ug/ml), and P
Evidence 7 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

S. typhimorium ATCC 14028

Source & Reference

NA

Other

l), Gram- E. coli ATCC 25922 (MIC 12.5 ug/ml), S. dysentariae ATCC 9752 (MIC 12.5 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumonia ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853) (MIC 12.5 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

K. pneumonia ATCC 10031

Source & Reference

NA

Other

ml), S. dysentariae ATCC 9752 (MIC 12.5 ug/ml), S. typhimorium ATCC 14028 (MIC 25 ug/ml), K. pneumonia ATCC 10031 (MIC 6.3 ug/ml), and P. aeruginosa ATCC 27853) (MIC 12.5 ug/ml).
Evidence 9 Activity

Activity

5% Hemolysis
Toxicity
>=200 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | >=200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide | Mol Cells | 2011